Insider trading

Period: 120 months Stock: EXEL Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

176 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

176 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

176 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

176 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
176 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
176 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

176 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
26 May 2026
Aftab Dana EVP, Research and Development
Sold at will
$2.19M 43,451 at 50.35
6.8%
Not planned
20 May 2026
Haley Patrick J. EVP, Commercial
Sold at will
$1.60M 32,110 at 49.81
8.2%
Not planned
18 May 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$332.64K 6,625 at 50.21
5.8%
Planned (10b5-1)
24 Feb 2026
Aftab Dana EVP, Research and Development
Sold at will
$2.13M 47,918 at 44.50
7.2%
Not planned
19 Feb 2026
Aftab Dana EVP, Research and Development
Sold at will
$1.32M 29,873 at 44.35
4.3%
Not planned
18 Feb 2026
Hefti Brenda SVP and General Counsel
Sold on a plan
$821.62K 18,669 at 44.01
16.2%
Planned (10b5-1)
17 Feb 2026
Haley Patrick J. EVP, Commercial
Sold at will 2×
$2.95M 67,814 at 43.52
15.1%
Not planned
21 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
20 Nov 2025
Haley Patrick J. EVP, Commercial · indirect
Sold at will 2×
$1.43M 34,187 at 41.88
100%
Sold half or more
20 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$421.10K 10,000 at 42.11
2.4%
Not planned
11 Nov 2025
Aftab Dana EVP, Research and Development
Sold at will
$2.06M 48,383 at 42.50
6.8%
Not planned
20 May 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.52M 34,387 at 44.06
7.7%
Not planned
16 May 2025
Peterson Amy C. EVP Prod Dev & Med Aff & CMO
Sold at will
$3.31M 72,776 at 45.47
13.5%
Not planned
15 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$6.06M 126,383 at 47.96
22.1%
Planned (10b5-1)
15 May 2025
Hessekiel Jeffrey EVP & General Counsel
Sold at will
$1.15M 25,000 at 46.18
3.5%
Not planned
14 May 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$426.80K 10,000 at 42.68
2.0%
Planned (10b5-1)
1 May 2025
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$58.81K 1,508 at 39.00
0.2%
Planned (10b5-1)
3 Mar 2025
Haley Patrick J. EVP, Commercial
Sold on a plan
$388.00K 10,000 at 38.80
2.8%
Planned (10b5-1)
24 Feb 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.95M 52,636 at 36.98
14.8%
Not planned
24 Feb 2025
Aftab Dana CSO/EVP Disc & Trans Research
Sold at will
$991.77K 26,987 at 36.75
5.0%
Not planned
29 Nov 2024
Hessekiel Jeffrey EVP & General Counsel
Sold at will
$2.20M 60,000 at 36.67
11.0%
Not planned
22 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$352.70K 10,000 at 35.27
3.5%
Planned (10b5-1)
18 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$1.43M 41,588 at 34.36
12.6%
Planned (10b5-1)
5 Nov 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$3.39M 96,986 at 35.00
16.3%
Planned (10b5-1)
1 Nov 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$1.71M 50,000 at 34.13
8.6%
Planned (10b5-1)
30 Oct 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$36.49K 1,162 at 31.40
0.2%
Planned (10b5-1)
28 Oct 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$709.75K 25,000 at 28.39
4.1%
Planned (10b5-1)
23 Sep 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$659.50K 25,000 at 26.38
4.0%
Planned (10b5-1)
26 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$515.80K 20,000 at 25.79
3.1%
Planned (10b5-1)
12 Aug 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold at will
$565.09K 20,883 at 27.06
4.0%
Not planned
7 Aug 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$2.38M 95,000 at 25.00
15.4%
Planned (10b5-1)
7 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$2.08M 80,000 at 25.97
11.3%
Planned (10b5-1)
7 Aug 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$357.00K 14,000 at 25.50
3.9%
Planned (10b5-1)
23 Feb 2024
Haley Patrick J. EVP, Commercial
Sold at will
$1.01M 47,020 at 21.45
10.9%
Not planned
14 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$1.17M 50,000 at 23.35
14.0%
Planned (10b5-1)
13 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$575.25K 25,000 at 23.01
4.5%
Planned (10b5-1)
12 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$318.35K 14,149 at 22.50
4.4%
Planned (10b5-1)
4 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$551.50K 25,000 at 22.06
4.3%
Planned (10b5-1)
30 Nov 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$550.25K 25,000 at 22.01
4.1%
Planned (10b5-1)
30 Aug 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$103.36K 4,600 at 22.47
1.1%
Planned (10b5-1)
3 Aug 2023
Haley Patrick J. EVP, Commercial
Sold at will
$631.53K 30,553 at 20.67
9.7%
Not planned
1 Aug 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$1.09M 55,710 at 19.63
8.9%
Planned (10b5-1)
5 Apr 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$778.99K 38,930 at 20.01
6.3%
Planned (10b5-1)
1 Mar 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$1.33M 77,860 at 17.13
12.9%
28 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$1.44M 82,490 at 17.50
19.0%
27 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$175.00 10 at 17.50
0.0%
6 Feb 2023
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$434.25K 25,000 at 17.37
8.9%
15 Dec 2022
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$317.60K 20,000 at 15.88
4.6%
12 Sep 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$717.60K 40,000 at 17.94
13.3%
27 May 2022
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$342.57K 18,812 at 18.21
7.3%
Showing 1–50 of 176. Page 1 of 4 Older →